{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:39:58Z","timestamp":1794883198339,"version":"4.9.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016937","name":"Michigan Technology Tri-Corridor","doi-asserted-by":"publisher","award":["085P1000817"],"award-info":[{"award-number":["085P1000817"]}],"id":[{"id":"10.13039\/100016937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["P30 CA046592"],"award-info":[{"award-number":["P30 CA046592"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004948","name":"Michigan Economic Development Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ccell.2019.10.002","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T11:14:25Z","timestamp":1573470865000},"page":"498-511.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":646,"title":["A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In\u00a0Vivo"],"prefix":"10.1016","volume":"36","author":[{"given":"Longchuan","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnapriya","family":"Chinnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"McEachern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne A.","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2019.10.002_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090327","article-title":"The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies","volume":"10","author":"Arora","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ccell.2019.10.002_bib2","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-16-2622","article-title":"Targeted degradation of BET proteins in triple-negative breast cancer","volume":"77","author":"Bai","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2019.10.002_bib3","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: a review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccell.2019.10.002_bib4","first-page":"55","article-title":"STAT signaling in the pathogenesis and treatment of myeloid malignancies","volume":"1","author":"Bar-Natan","year":"2012","journal-title":"JAKSTAT"},{"key":"10.1016\/j.ccell.2019.10.002_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3beta homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.10.002_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.06.006","article-title":"Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?","volume":"191","author":"Beebe","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ccell.2019.10.002_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-pharmtox-010715-103507","article-title":"Targeted protein degradation by small molecules","volume":"57","author":"Bondeson","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ccell.2019.10.002_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in\u00a0vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib10","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.131568898","article-title":"Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis","volume":"98","author":"Bowman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2019.10.002_bib11","doi-asserted-by":"crossref","first-page":"34133","DOI":"10.1074\/jbc.M304531200","article-title":"STATs dimerize in the absence of phosphorylation","volume":"278","author":"Braunstein","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib12","series-title":"BUSTER, 2.10.3","author":"Bricogne","year":"2017"},{"key":"10.1016\/j.ccell.2019.10.002_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The advantages of targeted protein degradation over inhibition: an RTK case study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/cancers6031579","article-title":"STAT3 activities and energy metabolism: dangerous liaisons","volume":"6","author":"Camporeale","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ccell.2019.10.002_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.15252\/embj.201592629","article-title":"Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency","volume":"35","author":"Carbognin","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2019.10.002_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"STAT3 target genes relevant to human cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ccell.2019.10.002_bib18","series-title":"Molecular Operating Environment (MOE)","author":"CCG","year":"2018"},{"key":"10.1016\/j.ccell.2019.10.002_bib19","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2019.10.002_bib20","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/en.2007-1148","article-title":"Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity","volume":"149","author":"Cernkovich","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ccell.2019.10.002_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jmedchem.6b01912","article-title":"Impact of target warhead and linkage vector on inducing protein degradation: comparison of bromodomain and extra-terminal (BET) degraders derived from triazolodiazepine (JQ1) and tetrahydroquinoline (I-BET726) BET inhibitor scaffolds","volume":"61","author":"Chan","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/ml100010j","article-title":"Structure-based design of conformationally constrained, cell-permeable STAT3 inhibitors","volume":"1","author":"Chen","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ccell.2019.10.002_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ccell.2019.10.002_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/MCB.24.1.258-269.2004","article-title":"Essential role of STAT3 in body weight and glucose homeostasis","volume":"24","author":"Cui","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2019.10.002_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the 'undruggable' cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2019.10.002_bib28","first-page":"e23060","article-title":"STAT heterodimers in immunity: a mixed message or a unique signal?","volume":"2","author":"Delgoffe","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.ccell.2019.10.002_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T\u00a0cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2019.10.002_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ccell.2019.10.002_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","article-title":"BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design","volume":"15","author":"Farnaby","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.10.002_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014241","article-title":"MYC activation is a hallmark of cancer initiation and maintenance","volume":"4","author":"Gabay","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.ccell.2019.10.002_bib34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib35","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ccell.2019.10.002_bib36","doi-asserted-by":"crossref","first-page":"25709","DOI":"10.1074\/jbc.270.43.25709","article-title":"Roles of protein-tyrosine phosphatases in Stat1 alpha-mediated cell signaling","volume":"270","author":"Haque","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib37","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1073\/pnas.94.16.8563","article-title":"Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1","volume":"94","author":"Haque","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2019.10.002_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ncponc0195","article-title":"Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer","volume":"2","author":"Haura","year":"2005","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.ccell.2019.10.002_bib39","doi-asserted-by":"crossref","first-page":"314ra185","DOI":"10.1126\/scitranslmed.aac5272","article-title":"AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer","volume":"7","author":"Hong","year":"2015","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.ccell.2019.10.002_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmet.2006.02.009","article-title":"Role of hepatic STAT3 in brain-insulin action on hepatic glucose production","volume":"3","author":"Inoue","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2019.10.002_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nm980","article-title":"Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in\u00a0vivo","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2019.10.002_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acschembio.7b00969","article-title":"Translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders","volume":"13","author":"Ishoey","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2019.10.002_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.189.1.63","article-title":"STAT3 is required for the gp130-mediated full activation of the c-myc gene","volume":"189","author":"Kiuchi","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2019.10.002_bib47","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2019.10.002_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS","volume":"523","author":"Kronke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.10.002_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2019.10.002_bib50","first-page":"41","article-title":"STAT3: a target to enhance antitumor immune response","volume":"344","author":"Lee","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ccell.2019.10.002_bib51","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do?","volume":"109","author":"Levy","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2019.10.002_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.ccell.2019.10.002_bib53","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2019.10.002_bib54","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1073\/pnas.0501643102","article-title":"STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2019.10.002_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ccell.2019.10.002_bib56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib57","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/jm801491w","article-title":"Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription 3: evaluation and molecular modeling","volume":"52","author":"Mandal","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib58","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1021\/acs.jmedchem.5b01321","article-title":"Targeting the Src homology 2 (SH2) domain of signal transducer and activator of transcription 6 (STAT6) with cell-permeable, phosphatase-stable phosphopeptide mimics potently inhibits Tyr641 phosphorylation and transcriptional activity","volume":"58","author":"Mandal","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib59","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2019.10.002_bib60","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1021\/ac502040v","article-title":"MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes","volume":"86","author":"McAlister","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ccell.2019.10.002_bib62","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014266","article-title":"Therapeutic strategies to inhibit MYC","volume":"4","author":"McKeown","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.ccell.2019.10.002_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.smim.2013.12.005","article-title":"Toward a new STATe: the role of STATs in mitochondrial function","volume":"26","author":"Meier","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ccell.2019.10.002_bib65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","article-title":"Targeted protein degradation by PROTACs","volume":"174","author":"Neklesa","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ccell.2019.10.002_bib66","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","article-title":"Plasticity in binding confers selectivity in ligand-induced protein degradation","volume":"14","author":"Nowak","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nchembio.2538","article-title":"Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation","volume":"14","author":"Olson","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ccell.2019.10.002_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs)\u2013\u2013past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ccell.2019.10.002_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cytogfr.2015.07.010","article-title":"Mutations leading to constitutive active gp130\/JAK1\/STAT3 pathway","volume":"26","author":"Pilati","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ccell.2019.10.002_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2019.10.002_bib73","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41467-019-09746-1","article-title":"The Stat3-Fam3a axis promotes muscle stem cell myogenic lineage progression by inducing mitochondrial respiration","volume":"10","author":"Sala","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2019.10.002_bib74","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1021\/acs.jmedchem.6b01872","article-title":"Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals)","volume":"61","author":"Schiedel","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib75","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cas.13525","article-title":"Mutations in the signal transducer and activator of transcription family of genes in cancer","volume":"109","author":"Shahmarvand","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ccell.2019.10.002_bib76","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0092-8674(94)90357-3","article-title":"Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions","volume":"76","author":"Shuai","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2019.10.002_bib77","first-page":"2995","article-title":"GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis","volume":"125","author":"Shulga","year":"2012","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ccell.2019.10.002_bib79","series-title":"GRADE, 1.2.13","author":"Smart","year":"2017"},{"key":"10.1016\/j.ccell.2019.10.002_bib80","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/S0040-4039(00)74672-7","article-title":"A general-method for the preparation of benzylic alpha,alpha-difluorophosphonic acids\u2013\u2013nonhydrolyzable mimetics of phosphotyrosine","volume":"33","author":"Smyth","year":"1992","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ccell.2019.10.002_bib81","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/mc.22438","article-title":"Non-canonical Stat3 signaling in cancer","volume":"55","author":"Srivastava","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ccell.2019.10.002_bib82","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2019.10.002_bib83","doi-asserted-by":"crossref","first-page":"29610","DOI":"10.1074\/jbc.M111.226209","article-title":"Mitochondrial-targeted signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species","volume":"286","author":"Szczepanek","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib84","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ccell.2019.10.002_bib85","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M112.378984","article-title":"The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain","volume":"288","author":"Tammineni","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2019.10.002_bib86","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations","volume":"47","author":"Tate","year":"2019","journal-title":"Cancer Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2019.10.002_bib88","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ccell.2019.10.002_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","article-title":"BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment","volume":"67","author":"Winter","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2019.10.002_bib90","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/13543784.2017.1351941","article-title":"Do STAT3 inhibitors have potential in the future for cancer therapy?","volume":"26","author":"Wong","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ccell.2019.10.002_bib91","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.939.65.3","article-title":"Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2019.10.002_bib92","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1101\/gad.1553707","article-title":"Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB","volume":"21","author":"Yang","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2019.10.002_bib93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cr.2008.41","article-title":"Roles of unphosphorylated STATs in signaling","volume":"18","author":"Yang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.ccell.2019.10.002_bib94","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer\u2013\u2013new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2019.10.002_bib95","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ccell.2019.10.002_bib96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tips.2015.10.001","article-title":"Feedback activation of STAT3 as a cancer drug-resistance mechanism","volume":"37","author":"Zhao","year":"2016","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610819304763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610819304763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:02:30Z","timestamp":1761523350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610819304763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1535610819304763"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2019.10.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736883448.793568163","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.736883448.793569002","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In\u00a0Vivo","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2019.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}